Consenso sobre la detección y el manejo de la prediabetes. Grupo de trabajo de consensos y guías clínicas de la Sociedad Española de Diabetes

  1. Manel Mata Cases
  2. Sara Artola
  3. Javier Escalada
  4. Patxi Ezkurra Loyola
  5. Juan Carlos Ferrer García
  6. José Antonio Fornos
  7. Juan Girbés
  8. Itxaso Rica
Journal:
Farmacéuticos comunitarios

ISSN: 1885-8619

Year of publication: 2014

Volume: 6

Issue: 4

Pages: 26-39

Type: Article

DOI: 10.5672/FC.2173-9218.(2014/VOL6).004.05 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Farmacéuticos comunitarios

Abstract

In Spain, according to the Di@bet.es study, 13.8% of the adult population suffers from diabetes and 14.8% from some form of prediabetes (Impaired Glucose Tolerance, Impaired Fasting Glucose or both). Since early detection of prediabetes can facilitate the implementation of therapeutic measures to prevent its progression to diabetes, we believe that preventive strategies in primary care and specialized clinical settings should be agreed. Screening for diabetes and prediabetes using a specific questionnaire (FINDRISC) and/or the measurement of fasting plasma glucose in high risk patients leads to detecting patients at risk of developing diabetes and it is necessary to consider how they should be managed. The intervention in lifestyle can reduce the progression to diabetes and reverse a prediabetic state to normal and is a cost-effective intervention. Some drugs, such as metformin, have also been shown effective in reducing the progression to diabetes but are not superior to non-pharmacological interventions. Finally, an improvement in some cardiovascular risk factors has been observed although there is no strong evidence supporting the effectiveness of screening in terms of morbility and mortality.